Skip to main content

Table 3 Overview of pharmaceutical companies contributing to IMI

From: Open innovation and external sources of innovation. An opportunity to fuel the R&D pipeline and enhance decision making?

 

Total number of teams active in IMI projects

Sanofi

51

GlaxoSmithKline

47

Johnson & Johnson

46

AstraZeneca

44

Novartis

36

Pfizer

34

Eli Lilly

32

Roche

31

Bayer

29

Boehringer Ingelheim

28

UCB

25

Novo Nordisk

21

Merck

20

Amgen

16

AbbVie

13

Merck & Co.

10

Takeda

7

BristolMyersSquibb

5

  1. Source: http://www.imi.europa.eu/projects-results/project-factsheets